OpenAI’s research highlights that ChatGPT is no longer a niche tool. Instead, it has entered mainstream workflows across personal and professional settings. The study classifies usage into several broad categories, capturing how individuals interact with the system in both structured and ad hoc ways.

OpenAI starts testing ads in ChatGPT while assuring users that privacy, trust, and unbiased answers will remain fully protected.

Users can connect data from their medical records and wellness apps so the chatbot can walk them through test results or compare insurance options. Still, OpenAI stressed that ChatGPT Health is not a replacement for a doctor.

CVC DIF, the infrastructure business of CVC, has entered exclusive negotiations to acquire an 88 percent stake in Celeste from Infravia Capital Partners.

AdventHealth, Baylor Scott & White, Boston Children’s, Cedars-Sinai and HCA Healthcare are among health systems that have signed on.